OneStream, Inc. Class A Common Stock OS
Set alert
As of Apr 1, 9:30 AM ET
- YTD
- +30.58%
- 1 year
- +5.82%
- Open
- 24.00
- Prev close
- 24.00
- Mkt cap
- 2.40B
- Vol
- 2.66M
- Avg vol
- 2.19M
- EPS
- -0.28
- P/E
- -169.01
- Div yield
- 0.00%
More statistics
- Low
- 24.00
- High
- 24.00
- Beta
- 1.99
- Inst. own
- 89.17%
- Dividend
- 0.00
- Earnings
- May 14, 2026
2Y chart
Events in this range
- Feb 11, 2025Earnings: 0.07; estimate 0.02; surprise 250%
- May 8, 2025Earnings: 0.04; estimate -0.03; surprise 233.33%
- Aug 7, 2025Earnings: 0.05; estimate 0.01; surprise 400%
- Nov 6, 2025Earnings: 0.08; estimate 0.02; surprise 300%
- Jan 7, 2026Downgrade: Rosenblatt · Buy → Neutral
- Jan 7, 2026Downgrade: Wolfe Research · Outperform → Peer Perform
- Jan 7, 2026Downgrade: TD Cowen · Buy → Hold
- Jan 8, 2026Downgrade: Raymond James · Outperform → Market Perform
- Jan 16, 2026Downgrade: JP Morgan · Neutral → Underweight
- Feb 26, 2026Earnings: 0.12; estimate 0.05; surprise 140%
- Feb 27, 2026Downgrade: BTIG · Buy → Neutral
Signals (84)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Mar 30, 2026 | 7 months ago |
| RSI: Overbought | Mar 27, 2026 | 7 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| RSI: Overbought | Jan 6, 2026 | 9 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| SMA: Bullish | Dec 22, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 22, 2025 | 10 months ago |
| SMA: Bearish | Dec 3, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 19, 2025 | 11 months ago |
| SMA: Bearish | Nov 11, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| RSI: Overbought | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 5, 2025 | 12 months ago |
| SMA: Bearish | Nov 4, 2025 | 12 months ago |
| SMA: Bullish | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 29, 2025 | 1 year ago |
| SMA: Bullish | Oct 27, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 22, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 10, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 9, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 7, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 6, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 1, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| RSI: Oversold | Aug 7, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| RSI: Oversold | Jul 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 30, 2025 | 1 year ago |
| SMA: Bearish | Jul 7, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| SMA: Bearish | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 26, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| RSI: Overbought | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 29, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| RSI: Overbought | May 9, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 16, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 4, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 18, 2025 | 1 year ago |
| RSI: Oversold | Mar 13, 2025 | 1 year ago |
| SMA: Bearish | Feb 12, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 12, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| SMA: Bearish | Feb 6, 2025 | 1 year ago |
| SMA: Bullish | Feb 4, 2025 | 1 year ago |
| SMA: Bearish | Feb 3, 2025 | 1 year ago |
| SMA: Bullish | Jan 30, 2025 | 1 year ago |
| SMA: Bearish | Jan 29, 2025 | 1 year ago |
| SMA: Bullish | Jan 28, 2025 | 1 year ago |
| SMA: Bearish | Jan 27, 2025 | 1 year ago |
| SMA: Bullish | Jan 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 16, 2025 | 1 year ago |
| RSI: Oversold | Jan 8, 2025 | 1 year ago |
| SMA: Bearish | Dec 13, 2024 | 1 year ago |
| SMA: Bullish | Dec 11, 2024 | 1 year ago |
| SMA: Bearish | Dec 5, 2024 | 1 year ago |
| SMA: Bullish | Dec 3, 2024 | 1 year ago |
| SMA: Bearish | Nov 27, 2024 | 1 year ago |
| SMA: Bullish | Nov 22, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 18, 2024 | 1 year ago |
| SMA: Bearish | Nov 15, 2024 | 1 year ago |
| SMA: Bullish | Nov 6, 2024 | 1 year ago |
| MACD: Buy Signal | Nov 6, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 1, 2024 | 2 years ago |
| SMA: Bearish | Oct 30, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 24, 2024 | 2 years ago |
| SMA: Bullish | Oct 23, 2024 | 2 years ago |
| SMA: Bearish | Oct 15, 2024 | 2 years ago |
| SMA: Bullish | Oct 14, 2024 | 2 years ago |
| SMA: Bearish | Oct 8, 2024 | 2 years ago |
| MACD: Sell Signal | Oct 3, 2024 | 2 years ago |
| RSI: Overbought | Sep 20, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 18, 2024 | 2 years ago |
| RSI: Overbought | Aug 30, 2024 | 2 years ago |
| RSI: Overbought | Aug 19, 2024 | 2 years ago |
| RSI: Overbought | Aug 15, 2024 | 2 years ago |
Key statistics
- Market cap
- 2.40B
- Enterprise value
- 5.22B
- Trailing P/E
- -169.01
- PEG ratio
- -1.57
- Price / sales
- 12.67
- Price / book
- 8.77
- Beta
- 1.99
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -5.64%
- Total cash
- 0
- Total debt
- 0
- Return on equity
- -5.49%
Analyst view
- Strong buy10
- Buy8
- Hold2
- Sell0
- Strong sell0
Next earnings
May 14, 2026
Expected May 14, 2026. Consensus EPS estimate 0.0495.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| May 14, 2026 | Mar 31, 2026 | 0.04 | — | — | — |
| Feb 26, 2026 | Dec 31, 2025 | 0.05 | 0.12 | +0.07 | +140.00% |
| Nov 6, 2025 | Sep 30, 2025 | 0.02 | 0.08 | +0.06 | +300.00% |
| Aug 7, 2025 | Jun 30, 2025 | 0.01 | 0.05 | +0.04 | +400.00% |
| May 8, 2025 | Mar 31, 2025 | -0.03 | 0.04 | +0.07 | +233.33% |
| Feb 11, 2025 | Dec 31, 2024 | 0.02 | 0.07 | +0.05 | +250.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 27, 2026 | BTIG | down | Buy | Neutral |
| Jan 16, 2026 | JP Morgan | down | Neutral | Underweight |
| Jan 8, 2026 | Raymond James | down | Outperform | Market Perform |
| Jan 7, 2026 | TD Cowen | down | Buy | Hold |
| Jan 7, 2026 | Wolfe Research | down | Outperform | Peer Perform |
| Jan 7, 2026 | Rosenblatt | down | Buy | Neutral |
About OneStream, Inc. Class A Common Stock
OneStream, Inc. delivers an integrated, adaptable software platform, enhanced with artificial intelligence capabilities, to clients across the United States and internationally. Their flagship offering, the Digital Finance Cloud platform, provides essential solutions for modern financial management. These include simplifying financial close and consolidation by automating various tasks and expertly navigating the intricate requirements and standards of financial reporting. The platform also supports comprehensive financial and operational planning, budgeting, forecasting, and detailed results analysis, not only for individual business units but also for harmonizing plans across the entire enterprise. Furthermore, it offers robust financial and operational reporting, ensuring clear, end-to-end visibility of analytics and crucial performance indicators for a diverse audience, including senior executives, finance experts, departmental leaders, and other collaborators. OneStream, Inc. caters to a broad clientele, comprising major corporations, mid-sized organizations, and governmental entities. The company was founded in 2012 and is based in Birmingham, Michigan.
- Sector
- Technology
- Industry
- Software - Application
- Country
- US
- Employees
- 1,500
- Website
- onestream.com
News
- Arteris (NASDAQ:AIP) and OneStream (NASDAQ:OS) Financial Comparison
- Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
- TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
- Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
- IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
- IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
- Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
- BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer
- Ziihera® (zanidatamab-hrii) Combinations Demonstrate Sustained Survival at Three Years in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma at ESMO 2026
- /C O R R E C T I O N - AbbVie/
Your note
Sign in to keep a note on OS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| COLBY CRAIG | Former | Sale | Jun 10, 2025 | 388,010 |
| HOHENSTEIN KEN | Officer | Stock Award(Grant) | Mar 18, 2026 | 1,820,850 |
| KINZER JOHN EDWARD | Director | Conversion of Exercise of derivative security | Dec 18, 2025 | 0 |
| KOEFOED WILLIAM A JR. | Chief Financial Officer | Sale | Dec 14, 2025 | 206,127 |
| LESHINSKI SCOTT | President | Stock Award(Grant) | Mar 18, 2026 | 378,458 |
| MARINER JONATHAN D | Director | Sale | Jan 5, 2026 | 7,130 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 8.45% | 8,580,460 | 205.93M | Dec 30, 2025 |
| T. Rowe Price Investment Management, Inc. | 7.66% | 7,779,413 | 186.71M | Dec 30, 2025 |
| NORGES BANK | 5.88% | 5,974,029 | 143.38M | Dec 30, 2025 |
| Kayne Anderson Rudnick Investment Management LLC | 4.79% | 4,867,636 | 116.82M | Dec 30, 2025 |
| Temasek Holdings (Private) Ltd | 4.20% | 4,266,714 | 102.40M | Dec 30, 2025 |
| DARLINGTON PARTNERS CAPITAL MANAGEMENT, LP | 3.78% | 3,839,405 | 92.15M | Dec 30, 2025 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Virtus Equity Trust-Virtus KAR Small-Cap Growth Fund | 2.74% | 2,786,675 | 66.88M | Dec 30, 2025 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 2.69% | 2,732,900 | 65.59M | Dec 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.46% | 2,499,967 | 60.00M | Dec 30, 2025 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 1.82% | 1,846,270 | 44.31M | Dec 30, 2025 |
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Growth Fund | 1.70% | 1,727,000 | 41.45M | Dec 30, 2025 |
| VANGUARD WORLD FUND-Vanguard Information Technology Index Fund | 1.63% | 1,658,701 | 39.81M | Nov 29, 2025 |